Tuhura Biosciences Stock Analysis
HURA Stock | 4.79 0.06 1.27% |
TuHURA Biosciences is undervalued with Real Value of 7.14 and Target Price of 15.0. The main objective of TuHURA Biosciences stock analysis is to determine its intrinsic value, which is an estimate of what TuHURA Biosciences is worth, separate from its market price. There are two main types of TuHURA Biosciences' stock analysis: fundamental analysis and technical analysis.
The TuHURA Biosciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and TuHURA Biosciences' ongoing operational relationships across important fundamental and technical indicators.
TuHURA |
TuHURA Stock Analysis Notes
The company had not issued any dividends in recent years. TuHURA Biosciences had 1:35 split on the 18th of October 2024.TuHURA Biosciences Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. TuHURA Biosciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding TuHURA Biosciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
TuHURA Biosciences had very high historical volatility over the last 90 days | |
TuHURA Biosciences has a very high chance of going through financial distress in the upcoming years | |
TuHURA Biosciences was previously known as KTRA Old and was traded on NASDAQ Exchange under the symbol KTRA. | |
Net Loss for the year was (29.32 M) with profit before overhead, payroll, taxes, and interest of 0. | |
TuHURA Biosciences generates negative cash flow from operations | |
TuHURA Biosciences has a frail financial position based on the latest SEC disclosures | |
Latest headline from gurufocus.com: Innovent and ASK Pharm Jointly Announce NMPA Approval of Limertinib, a Third-generation EGFR ... |
TuHURA Largest EPS Surprises
Earnings surprises can significantly impact TuHURA Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2023-09-19 | 2023-06-30 | -36.92 | -68.25 | -31.33 | 84 | ||
2023-05-11 | 2023-03-31 | -6.65 | -67.9 | -61.25 | 921 |
TuHURA Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 141.65 M.TuHURA Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (7.73) | (7.34) | |
Return On Capital Employed | (44.72) | (42.48) | |
Return On Assets | (7.73) | (7.34) | |
Return On Equity | 16.93 | 17.77 |
Technical Drivers
As of the 18th of January 2025, TuHURA Biosciences has the risk adjusted performance of 0.0108, and Coefficient Of Variation of 54002.57. TuHURA Biosciences technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices.TuHURA Biosciences Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. TuHURA Biosciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for TuHURA Biosciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
TuHURA Biosciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific TuHURA Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on TuHURA Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases TuHURA Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ng George K over two weeks ago Acquisition by Ng George K of 51275 shares of TuHURA Biosciences at 4.11 subject to Rule 16b-3 | ||
Dearborn Dan over two months ago Acquisition by Dearborn Dan of 489848 shares of TuHURA Biosciences at 4.94 subject to Rule 16b-3 |
TuHURA Biosciences Predictive Daily Indicators
TuHURA Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of TuHURA Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
TuHURA Biosciences Forecast Models
TuHURA Biosciences' time-series forecasting models are one of many TuHURA Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary TuHURA Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About TuHURA Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how TuHURA Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling TuHURA shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as TuHURA Biosciences. By using and applying TuHURA Stock analysis, traders can create a robust methodology for identifying TuHURA entry and exit points for their positions.
Last Reported | Projected for Next Year |
Current TuHURA Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. TuHURA analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. TuHURA analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
15.0 | Buy | 1 | Odds |
Most TuHURA analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand TuHURA stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of TuHURA Biosciences, talking to its executives and customers, or listening to TuHURA conference calls.
TuHURA Stock Analysis Indicators
TuHURA Biosciences stock analysis indicators help investors evaluate how TuHURA Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading TuHURA Biosciences shares will generate the highest return on investment. By understating and applying TuHURA Biosciences stock analysis, traders can identify TuHURA Biosciences position entry and exit signals to maximize returns.
Begin Period Cash Flow | 14.3 M | |
Total Stockholder Equity | -1.6 M | |
Capital Lease Obligations | 20.8 K | |
Property Plant And Equipment Net | 203 K | |
Cash And Short Term Investments | 3.7 M | |
Net Invested Capital | 757.4 K | |
Cash | 3.7 M | |
200 Day M A | 6.0151 | |
50 Day M A | 5.7598 | |
Net Interest Income | 71 K | |
Total Current Liabilities | 3.6 M | |
Investments | -1.3 M | |
Interest Expense | 18.7 K | |
Stock Based Compensation | 478.9 K | |
Long Term Debt | 2.3 M | |
Common Stock Shares Outstanding | 68 M | |
Free Cash Flow | -12 M | |
Operating Income | -29.8 M | |
Other Current Assets | 493.8 K | |
Accounts Payable | 1.9 M | |
Net Debt | -1.3 M | |
Depreciation | 177.4 K | |
Other Operating Expenses | 29.8 M | |
Non Current Assets Total | 203 K | |
Liabilities And Stockholders Equity | 4.4 M |
Complementary Tools for TuHURA Stock analysis
When running TuHURA Biosciences' price analysis, check to measure TuHURA Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TuHURA Biosciences is operating at the current time. Most of TuHURA Biosciences' value examination focuses on studying past and present price action to predict the probability of TuHURA Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TuHURA Biosciences' price. Additionally, you may evaluate how the addition of TuHURA Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |